LivaNova PLC LIVN Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$89.99 down $1.15, 1.26% at close Nov 6
Last close · Previous close $91.14
- Market cap
- $4.96BAt the Nov 6 close
- P/E ratio
- 30.00On last 12 months’ EPS
- Diluted EPS
- $3.00Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$89.99down $1.15, 1.26%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$91.14Nov 5
- Volume444.00KNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume757.73KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $49.83 to $99.38; now $89.99
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
LIVN beat the S&P 500 in 5 of 7 periods.
| Period | LIVN and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | LIVN: up 20.1% S&P 500: down 5.6% | LIVN beat the S&P 500 by 25.7 percentage points Beat |
| 3M | LIVN: up 18.8% S&P 500: down 4.1% | LIVN beat the S&P 500 by 22.9 percentage points Beat |
| YTD | LIVN: up 46.3% S&P 500: up 8.7% | LIVN beat the S&P 500 by 37.6 percentage points Beat |
| 1Y | LIVN: up 81.5% S&P 500: up 10.9% | LIVN beat the S&P 500 by 70.6 percentage points Beat |
| Long term | ||
| 3Y | LIVN: up 85.2% S&P 500: up 75.0% +22.8% vs +20.5% a year | LIVN beat the S&P 500 by 10.2 percentage points Beat |
| 5Y | LIVN: down 2.5% S&P 500: up 67.8% −0.5% vs +10.9% a year | LIVN trailed the S&P 500 by 70.3 percentage points Trailed |
| 10Y | LIVN: up 100.9% S&P 500: up 313.1% +7.2% vs +15.2% a year | LIVN trailed the S&P 500 by 212.2 percentage points Trailed |
$10,000 invested in LIVN 10 years ago (Nov 4, 2016) would be worth about $20,092 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
LIVN beat the S&P 500 in 5 of 7 periods.
| Period | LIVN and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | LIVN: up 20.1% S&P 500: down 5.6% | LIVN beat the S&P 500 by 25.7 percentage points Beat |
| 3M | LIVN: up 18.8% S&P 500: down 4.3% | LIVN beat the S&P 500 by 23.1 percentage points Beat |
| YTD | LIVN: up 46.3% S&P 500: up 7.8% | LIVN beat the S&P 500 by 38.5 percentage points Beat |
| 1Y | LIVN: up 81.5% S&P 500: up 9.7% | LIVN beat the S&P 500 by 71.8 percentage points Beat |
| Long term | ||
| 3Y | LIVN: up 85.2% S&P 500: up 68.8% +22.8% vs +19.1% a year | LIVN beat the S&P 500 by 16.4 percentage points Beat |
| 5Y | LIVN: down 2.5% S&P 500: up 56.9% −0.5% vs +9.4% a year | LIVN trailed the S&P 500 by 59.4 percentage points Trailed |
| 10Y | LIVN: up 100.9% S&P 500: up 252.6% +7.2% vs +13.4% a year | LIVN trailed the S&P 500 by 151.7 percentage points Trailed |
$10,000 invested in LIVN 10 years ago (Nov 4, 2016) would be worth about $20,092 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$130.95
Closing high on . Now 31.3% below that record.
Split-adjusted daily closes since Oct 19, 2015.
Stock splits
LIVN hasn’t split since its price history begins in 2015.
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Sep 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
30.0×The Nov 6 close ÷ diluted EPS over the last 12 months ($3.00)
The range covers daily P/E ratios from Oct 28, 2021 to Nov 6, 2026, each based on the previous 12 months of earnings.
LIVN trades at 30.0× its earnings over the last 12 months, below its 5-year median of 41.7×. In plain terms, buyers are paying about $30 for each $1 of profit from the past year. How to read P/E
Other valuation measures
- 3.3×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 3.6×Book value as of Sep 30, 2026
Price relative to accounting equity (book value) per share on the Sep 30, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - 21.6×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - 2.60%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $4.74BAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Sep 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own LIVN DCF in Excel. Value LivaNova with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY26, the quarter ended Sep 30, 2026. “Last 12 months” means the four quarters from Oct 1, 2025 to Sep 30, 2026, and balance-sheet figures are as of Sep 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $1.51Bup 11.7%
- Net income
- $196.06M
- Diluted EPS
- $3.00
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY24 (Dec 31, 2024) | $321.83M | $55.89M | $1.03 |
| Q1 FY25 (Mar 31, 2025) | $316.86M | −$327.32M | −$6.01 |
| Q2 FY25 (Jun 30, 2025) | $352.52M | $27.16M | $0.50 |
| Q3 FY25 (Sep 30, 2025) | $357.75M | $26.78M | $0.49 |
| Q4 FY25 (Dec 31, 2025) | $360.92M | $30.91M | $0.56 |
| Q1 FY26 (Mar 31, 2026) | $362.26M | $22.29M | $0.40 |
| Q2 FY26 (Jun 30, 2026) | $390.59M | $108.57M | $1.93 |
| Q3 FY26 (Sep 30, 2026) | $393.15M | $34.29M | $0.11 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $1.04B | −$135.82M | −$2.68 |
| FY22 (Dec 31, 2022) | $1.02B | −$86.25M | −$1.61 |
| FY23 (Dec 31, 2023) | $1.15B | $17.55M | $0.32 |
| FY24 (Dec 31, 2024) | $1.25B | $63.23M | $1.16 |
| FY25 (Dec 31, 2025) | $1.39B | −$242.47M | −$4.45 |
Margins
- Gross 67.8%
- Operating 10.7%
- Net 13.0%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $129.02MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$237.86MLast 12 months
- Capital spending$108.85MLast 12 months
- 8.6%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $2.00KLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
0% of free cash flow
Balance sheet
- $632.86MAs of Sep 30, 2026
Cash plus short- and long-term marketable securities on the Sep 30, 2026 balance sheet.
- Total debt$347.88MAs of Sep 30, 2026
- Net cash$284.98MAs of Sep 30, 2026
- 1.46As of Sep 30, 2026
Current assets divided by current liabilities on the Sep 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.25As of Sep 30, 2026
Total debt divided by shareholders’ equity on the Sep 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 8 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✓Return on assets improved: passed
- ✓Operating cash flow exceeded net income: passed
- ✓Long-term debt fell relative to assets: passed
- ✓Current ratio improved: passed
- ✗Share count didn’t rise: not passed
- ✓Gross margin improved: passed
- ✓Asset turnover (revenue ÷ assets) improved: passed
- 15.4%Last 12 months
Over the last 12 months, LivaNova’s net income was 15.4% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 7.5%Last 12 months
Over the last 12 months, LivaNova’s net income was 7.5% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
About LivaNova PLC
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through medical technologies, delivering life-changing solutions in select neurological and cardiac conditions. Headquartered in London, LivaNova employs approximately 2,900 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals, and healthcare systems worldwide.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- United Kingdom
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
LIVN news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
LIVN stock FAQ
What is LIVN stock’s price today?
LivaNova (LIVN) traded at $89.99 at the close on , down $1.15 (1.26%) from the previous close of $91.14. Over the past 52 weeks it has traded between $49.83 and $99.38.
If you invested $1,000 in LIVN 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in LIVN on would be worth about $2,009 at the close on , a total return of +100.9%. The same $1,000 would be worth $975 if invested five years ago and $1,815 if invested one year ago. Past performance doesn’t predict future returns.
What is LivaNova’s market cap?
LivaNova’s market capitalization is about $5.0 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $89.99 (how market cap works). LivaNova reported 55.09M shares outstanding at the end of its latest quarter ().
What is LIVN’s P/E ratio?
LIVN trades at 30.0 times its diluted earnings over the four quarters to ($3.00 per share), at the close. Over the past five years its P/E has ranged from 21.0 to 991.4, with a median of 41.7. (How the P/E ratio works.)
How much revenue does LivaNova make?
LivaNova reported $1.5 billion of revenue over the four quarters to , up 11.7% from the twelve months before. In its latest quarter (Q3 FY26, ended ) revenue was $393.1 million, up 9.9% from a year earlier.
Is LivaNova profitable?
Yes. LivaNova earned $196.1 million of net income over the four quarters to , a net margin of 13.0%, and its operating margin was 10.7% (what margins tell you).
What are LIVN’s earnings per share?
LIVN’s diluted earnings per share were $3.00 over the four quarters to , compared with −$3.99 in the twelve months before. The latest quarter (Q3 FY26) brought $0.11 per share, against $0.49 a year earlier (how EPS works).
Does LIVN pay a dividend?
LivaNova hasn’t paid a dividend in the last twelve months.
What is LIVN’s 52-week high and low?
Over the past 52 weeks LIVN has traded as low as $49.83 and as high as $99.38. At $89.99 at the close on , it is 9.4% below that high and 80.6% above the low.
What is LIVN’s all-time high?
LIVN’s highest closing price was $130.95 on , adjusted for stock splits. At $89.99 at the close on , it is 31.3% below that record.
Has LIVN stock ever split?
No. LIVN hasn’t split since its price history begins in 2015.
How has LIVN stock performed?
Including dividends and measured to the close on , LIVN has returned +46.3% so far this year and +81.5% over the past year, and −2.5% over five years (−0.5% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is LivaNova in?
LivaNova is in the Healthcare sector and the Medical Devices industry, and is headquartered in United Kingdom.
What exchange does LIVN trade on?
LivaNova trades on the Nasdaq under the ticker symbol LIVN. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.